Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

On January 31, 2013 (Australian Eastern Daylight Time), REVA Medical, Inc. filed its Appendix 4C Quarterly Report (Quarterly
Report) for the three months ended December 31, 2012 with the Australian Securities Exchange (the ASX). A copy of the Quarterly Report is furnished hereto as Exhibit 99.1.

The Quarterly Report includes a statement of cash flows prepared in compliance with the requirements of Australian law and the ASX
Listing Rules.

Cash as of December 31, 2012 as reported in the Quarterly Report was approximately $38.9 million.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibits.

ExhibitNo.

Description

99.1

Australian Appendix 4C Quarterly Report for the period ended December 31, 2012.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

REVA Medical, Inc.

Date: January 31, 2013

/s/ Katrina L. Thompson

Katrina L. Thompson

Chief Financial Officer

(principal financial and accounting officer)

Index to Exhibits

ExhibitNumber

Description of Exhibits

99.1

Australian Appendix 4C Quarterly Report for the period ended December 31, 2012.

Site Links

Based on public records. Inadvertent errors are possible. Getfilings.com does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC.